# US 2025/0143919 A1 · Skin freezing systems for treating acne and skin conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0143919 A1
- Document ID: US20250143919A1
- Status: Published application
- Kind: A1
- Application number: 18/882,608
- Filed: 2024-09-11
- Published: 2025-05-08
- Earliest claimed: 2016-05-10
- Assignees: Zeltiq Aesthetics, Inc.
- Applicants: Zeltiq Aesthetics, Inc.
- Inventors: Leonard C. DeBenedictis; Joel N. Jimenez Lozano; Like Zeng; George Frangineas, Jr.; Linda Pham
- Web page: https://patentgrep.com/patent/US20250143919A1

## CPC

- A61F 7/0085: {Devices for generating hot or cold treatment fluids}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61B 2090/0463: {against cooling or freezing}
- A61F 2007/0052: {for treatment of skin or hair}
- A61F 2007/0056: {for cooling}
- A61F 2007/0063: {for cooling}
- A61F 2007/0076: {remote from the spot to be heated or cooled}
- A61F 2007/0086: {with a thermostat}
- A61F 2007/0093: {programmed}
- A61F 2007/0095: {with a temperature indicator}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method and system in accordance with a particular embodiments of the technology includes applying a substance onto skin of a human subject. An applicator is then applied to the subject to cool a region of the subject. After cooling the tissue, a nucleation initiator is used to initiate a freeze event in the tissue. The nucleation initiator can be an ice crystal that inoculates the skin upon contact to create a predictable freeze event therein. The time of contact between the ice crystal and the skin can be controlled to achieve desired effects.

## Claims

### Claim 1

A method for predictably freezing a subject's skin at a desired predictable time, comprising:
lowering a temperature of the skin below a freezing point of fluid in the skin so that the skin is at a first temperature;
causing an ice crystal to contact the skin to inoculate the skin and to create a predictable freeze event therein; and
controlling a time of contact between the ice crystal and the skin so that the predictable freeze occurs at a desired time.

### Claim 2 (depends on 1)

The method of claim 1, further comprising physically contacting a surface of the skin with the ice crystal.

### Claim 3 (depends on 1)

The method of claim 1, further comprising introducing the ice crystal into the subject using a catheter so that the ice crystal contacts a dermal layer of the skin.

### Claim 4 (depends on 1)

The method of claim 1, further comprising forming the ice crystal in a cryoprotectant solution located on the skin.

### Claim 5 (depends on 4)

The method of claim 4, further comprising
maintaining the temperature of the skin at the first temperature for a first treatment period, wherein the first temperature is more than 7 degrees C. below the freezing point of the fluid in the skin; and
after the first treatment period, cooling the cryoprotectant solution from a temperature above a freezing point of the cryoprotectant solution to a temperature below the freezing point of the cryoprotectant solution to form the ice crystal therein.

### Claim 6 (depends on 4)

The method of claim 4, further comprising diluting a cryoprotectant concentration on a skin surface so as to raise a freezing point of the diluted concentration to a value above a temperature of the cryoprotectant solution so that formation of the ice crystal does not require that the skin temperature be lowered below the first temperature.

### Claim 7 (depends on 1)

The method of claim 1, further comprising using ultrasound energy to create the ice crystal either in the skin or in a substance in contact with the skin.

### Claim 8 (depends on 1)

The method of claim 1, wherein the first temperature is at least 10 degrees C. below the freezing point of the fluid in the skin prior to inoculating the skin.

### Claim 9 (depends on 8)

The method of claim 8, further comprising:
maintaining the first temperature for a first treatment period;
after the first treatment period has expired, lowering the skin temperature to a second temperature lower than the first temperature to create the ice crystal; and
maintaining the second temperature for a second treatment period.

### Claim 10 (depends on 9)

The method of claim 9, further comprising after the second treatment period has expired, rapidly warming a surface of the skin to a third temperature higher than the first or second temperature.

### Claim 11 (depends on 10)

The method of claim 10, further comprising:
maintaining the third temperature for a third treatment period, wherein the third temperature is a cold therapeutic temperature within 5 degrees C. of the freezing point which causes minimal damage to epidermal tissue; and
allowing the surface of the skin to warm to room temperature or above room temperature.

### Claim 12 (depends on 1)

The method of claim 1, wherein the first temperature is less than 3 degrees C. below the freezing point of the fluid prior to inoculating the skin.

### Claim 13 (depends on 1)

The method of claim 1, further comprising maintaining the first temperature for a predetermined period of time to create a predetermined level of skin supercooling prior to causing the ice crystal to contact the skin.

### Claim 14 (depends on 1)

The method of claim 1, further comprising
detecting the freeze event; and
controlling a length of time of the freeze event by controlling when the temperature of the skin is raised to a temperature above the freezing point of the fluid in the skin based on detection of the freeze event.

### Claim 15 (depends on 1)

The method of claim 1, further comprising forming the ice crystal prior to lowering the temperature of the skin below the freezing temperature of the fluid.

### Claim 16 (depends on 15)

The method of claim 15, further comprising forming the ice crystal after lowering the temperature of the skin below the freezing temperature of the fluid.

### Claim 17 (depends on 1)

The method of claim 1, further comprising using a coupling media in contact with the skin to aid in removing heat from the skin, and wherein the coupling media includes an ice nucleating agent, a hydrogel, and/or a freezing point depressant.

### Claim 18 (depends on 1)

The method of claim 1, further comprising:
applying a coupling media to the skin, the coupling media having a medium therein capable of forming ice crystals; and
establishing a temperature of an applicator in thermal contact with the coupling media to predictably freeze a portion of the medium in physical contact with a skin surface such that the frozen portion of the medium causes freezing of the skin.

### Claim 19 (depends on 18)

The method of claim 18, wherein the coupling media comprises a crosslinked polymer which includes water, and wherein the coupling media has a specific ratio of water-monomer-crosslinker content so as to have a predetermined freezing point higher than either −40, −25, −20, or −15 degrees C.

### Claim 20 (depends on 19)

The method of claim 19, wherein the crosslinked polymer is a hydrogel.

### Claim at position 21

-40. (canceled)
